Guru Ownership Trend
Guru Analysis for Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.4 M.
Top institutional holders include Chuck Royce and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.78 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 162.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Compass Therapeutics, Inc. (CMPX)
Major holders include Chuck Royce ($1.54 M), Cliff Asness ($833,521). According to the latest reported data, 2 tracked investment managers collectively hold approximately 441,206 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.78 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CMPX. The total reported sell value was $276,500.
Yes, 1 managers opened new positions in CMPX, and 1 increased their existing holdings. The total reported buy value was $2.05 M.